These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 34608474)
1. A camptothecin prodrug induces mitochondria-mediated apoptosis in cancer cells with cascade activations. Luo X; Chi X; Lin Y; Yang Z; Lin H; Gao J Chem Commun (Camb); 2021 Oct; 57(84):11033-11036. PubMed ID: 34608474 [TBL] [Abstract][Full Text] [Related]
2. Multi-stimuli responsive polymeric prodrug micelles for combined chemotherapy and photodynamic therapy. Hu C; Zhuang W; Yu T; Chen L; Liang Z; Li G; Wang Y J Mater Chem B; 2020 Jun; 8(24):5267-5279. PubMed ID: 32441291 [TBL] [Abstract][Full Text] [Related]
3. Red light triggered photodynamic-chemo combination therapy using a prodrug caged by photosensitizer. Xu G; Zhang HX; Li XQ; Yang DC; Liu JY Eur J Med Chem; 2021 Apr; 215():113251. PubMed ID: 33611187 [TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species-activatable camptothecin polyprodrug based dextran enhances chemotherapy efficacy by damaging mitochondria. Zhang T; Ma X; Bai S; Wang Y; Zhang X; Lu Y; Wen F; Xue P; Kang Y; Xu Z J Mater Chem B; 2020 Feb; 8(6):1245-1255. PubMed ID: 31957760 [TBL] [Abstract][Full Text] [Related]
5. Stimulus-Responsive Nano-Prodrug Strategies for Cancer Therapy: A Focus on Camptothecin Delivery. Chu B; Deng H; Niu T; Qu Y; Qian Z Small Methods; 2024 Aug; 8(8):e2301271. PubMed ID: 38085682 [TBL] [Abstract][Full Text] [Related]
6. ROS-cleavable diselenide nanomedicine for NIR-controlled drug release and on-demand synergistic chemo-photodynamic therapy. Zhu R; He Q; Li Z; Ren Y; Liao Y; Zhang Z; Dai Q; Wan C; Long S; Kong L; Fan W; Yu W Acta Biomater; 2022 Nov; 153():442-452. PubMed ID: 36179978 [TBL] [Abstract][Full Text] [Related]
7. Supramolecular Crafting of Self-Assembling Camptothecin Prodrugs with Enhanced Efficacy against Primary Cancer Cells. Su H; Zhang P; Cheetham AG; Koo JM; Lin R; Masood A; Schiapparelli P; Quiñones-Hinojosa A; Cui H Theranostics; 2016; 6(7):1065-74. PubMed ID: 27217839 [TBL] [Abstract][Full Text] [Related]
8. Reduction stimuli-responsive unimolecular polymeric prodrug based on amphiphilic dextran-framework for antitumor drug delivery. Bai S; Gao YE; Ma X; Shi X; Hou M; Xue P; Kang Y; Xu Z Carbohydr Polym; 2018 Feb; 182():235-244. PubMed ID: 29279120 [TBL] [Abstract][Full Text] [Related]
9. ROS-Responsive Mitochondria-Targeting Blended Nanoparticles: Chemo- and Photodynamic Synergistic Therapy for Lung Cancer with On-Demand Drug Release upon Irradiation with a Single Light Source. Yue C; Yang Y; Zhang C; Alfranca G; Cheng S; Ma L; Liu Y; Zhi X; Ni J; Jiang W; Song J; de la Fuente JM; Cui D Theranostics; 2016; 6(13):2352-2366. PubMed ID: 27877240 [TBL] [Abstract][Full Text] [Related]
10. Photodynamic PEG-coated ROS-sensitive prodrug nanoassemblies for core-shell synergistic chemo-photodynamic therapy. Sun B; Chen Y; Yu H; Wang C; Zhang X; Zhao H; Chen Q; He Z; Luo C; Sun J Acta Biomater; 2019 Jul; 92():219-228. PubMed ID: 31078764 [TBL] [Abstract][Full Text] [Related]
11. Polymer Prodrug-Based Nanoreactors Activated by Tumor Acidity for Orchestrated Oxidation/Chemotherapy. Li J; Li Y; Wang Y; Ke W; Chen W; Wang W; Ge Z Nano Lett; 2017 Nov; 17(11):6983-6990. PubMed ID: 28977746 [TBL] [Abstract][Full Text] [Related]
12. NIR-Light-Activated Combination Therapy with a Precise Ratio of Photosensitizer and Prodrug Using a Host-Guest Strategy. Chen H; Zeng X; Tham HP; Phua SZF; Cheng W; Zeng W; Shi H; Mei L; Zhao Y Angew Chem Int Ed Engl; 2019 Jun; 58(23):7641-7646. PubMed ID: 30980463 [TBL] [Abstract][Full Text] [Related]
13. Reactive oxygen species activated by mitochondria-specific camptothecin prodrug for enhanced chemotherapy. Guo Z; Wang Z; Liang R; Tian H; Chen X; Chen M Bosn J Basic Med Sci; 2022 Oct; 22(6):934-948. PubMed ID: 35801419 [TBL] [Abstract][Full Text] [Related]
14. Near Infrared-Activatable Methylene Blue Polypeptide Codelivery of the NO Prodrug via π-π Stacking for Cascade Reactive Oxygen Species Amplification-Mediated Photodynamic Therapy. Zhang Y; Zhao P; Chen X; Xu C; Guo J; Qu X; Hu X; Gao H; Huang P; Zhang J ACS Appl Mater Interfaces; 2023 Mar; 15(10):12750-12765. PubMed ID: 36852940 [TBL] [Abstract][Full Text] [Related]
15. CD147 Monoclonal Antibody Targeted Reduction-Responsive Camptothecin Polyphosphoester Nanomedicine for Drug Delivery in Hepatocellular Carcinoma Cells. Tian H; Huang Y; He J; Zhang M; Ni P ACS Appl Bio Mater; 2021 May; 4(5):4422-4431. PubMed ID: 35006854 [TBL] [Abstract][Full Text] [Related]
16. Dual-Activated Nano-Prodrug for Chemo-Photodynamic Combination Therapy of Breast Cancer. Lu Z; Xu G; Yang X; Liu S; Sun Y; Chen L; Liu Q; Liu J Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555298 [TBL] [Abstract][Full Text] [Related]
17. Mitochondria-specific drug release and reactive oxygen species burst induced by polyprodrug nanoreactors can enhance chemotherapy. Zhang W; Hu X; Shen Q; Xing D Nat Commun; 2019 Apr; 10(1):1704. PubMed ID: 30979885 [TBL] [Abstract][Full Text] [Related]
18. Self-sufficing H2O2-responsive nanocarriers through tumor-specific H2O2 production for synergistic oxidation-chemotherapy. Li J; Ke W; Wang L; Huang M; Yin W; Zhang P; Chen Q; Ge Z J Control Release; 2016 Mar; 225():64-74. PubMed ID: 26806789 [TBL] [Abstract][Full Text] [Related]
19. Bone-Targeting Prodrug Mesoporous Silica-Based Nanoreactor with Reactive Oxygen Species Burst for Enhanced Chemotherapy. Tong F; Ye Y; Chen B; Gao J; Liu L; Ou J; van Hest JCM; Liu S; Peng F; Tu Y ACS Appl Mater Interfaces; 2020 Aug; 12(31):34630-34642. PubMed ID: 32635715 [TBL] [Abstract][Full Text] [Related]
20. The self-assembly of anticancer camptothecin-dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy. Kim SH; Kaplan JA; Sun Y; Shieh A; Sun HL; Croce CM; Grinstaff MW; Parquette JR Chemistry; 2015 Jan; 21(1):101-5. PubMed ID: 25384556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]